Regulatory T cells in obesity: the leptin connection.

[1]  R. Klingenberg,et al.  Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[2]  M. Hurles,et al.  Large, rare chromosomal deletions associated with severe early-onset obesity , 2010, Nature.

[3]  E. Maury,et al.  Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome , 2010, Molecular and Cellular Endocrinology.

[4]  Tsutomu Takeuchi,et al.  Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells , 2009, Nature.

[5]  S. O’Rahilly,et al.  Human genetics illuminates the paths to metabolic disease , 2009, Nature.

[6]  T. Chitnis,et al.  Body size and risk of MS in two cohorts of US women , 2009, Neurology.

[7]  M. Dietrich,et al.  Feeding signals and brain circuitry , 2009, The European journal of neuroscience.

[8]  A. Butler,et al.  Obesity accelerates thymic aging. , 2009, Blood.

[9]  J. Mauer,et al.  MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. , 2009, Cell metabolism.

[10]  B. Wisse,et al.  Does hypothalamic inflammation cause obesity? , 2009, Cell metabolism.

[11]  M. Fessler,et al.  Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome , 2009, Current opinion in lipidology.

[12]  R. Robertson,et al.  β-Cell deterioration during diabetes: what's in the gun? , 2009, Trends in Endocrinology & Metabolism.

[13]  A. Klip,et al.  Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells , 2009, Archives of physiology and biochemistry.

[14]  Michael Famulok,et al.  The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity , 2009, The Journal of experimental medicine.

[15]  H. Björkbacka,et al.  Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease , 2009, Journal of internal medicine.

[16]  V. Bourlier,et al.  Role of macrophage tissue infiltration in obesity and insulin resistance. , 2009, Diabetes & metabolism.

[17]  T. Kadowaki,et al.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity , 2009, Nature Medicine.

[18]  Carey N. Lumeng,et al.  T-ing up inflammation in fat , 2009, Nature Medicine.

[19]  Christophe Benoist,et al.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.

[20]  B. Fox,et al.  Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects. , 2009, Current molecular medicine.

[21]  J. Zieleński,et al.  Normalization of Obesity-Associated Insulin Resistance through Immunotherapy: CD4+ T Cells Control Glucose Homeostasis , 2009, Nature Medicine.

[22]  A. Garfield,et al.  Role of central melanocortin pathways in energy homeostasis , 2009, Trends in Endocrinology & Metabolism.

[23]  H. Björkbacka,et al.  Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells , 2009, Circulation research.

[24]  Shailendra Giri,et al.  Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis1 , 2009, The Journal of Immunology.

[25]  K. Clément,et al.  Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice , 2009, Nature Medicine.

[26]  G. Hansson,et al.  Vaccination against atherosclerosis? Induction of atheroprotective immunity , 2009, Seminars in Immunopathology.

[27]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[28]  J. Friedman.  Obesity: Causes and control of excess body fat , 2009, Nature.

[29]  A. Thomson,et al.  Immunoregulatory functions of mTOR inhibition , 2009, Nature Reviews Immunology.

[30]  B. Jenks,et al.  Regulation of Proopiomelanocortin Gene Expression , 2009, Annals of the New York Academy of Sciences.

[31]  H. Pownall,et al.  The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance. , 2009, Current opinion in investigational drugs.

[32]  S. O’Rahilly,et al.  Leptin: a pivotal regulator of human energy homeostasis. , 2009, The American journal of clinical nutrition.

[33]  T. Horvath,et al.  Fuel utilization by hypothalamic neurons: roles for ROS , 2009, Trends in Endocrinology & Metabolism.

[34]  G. Berglund,et al.  Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease , 2009, Journal of internal medicine.

[35]  M. Maghnie,et al.  Thyroid function and structure are affected in childhood obesity. , 2008, The Journal of clinical endocrinology and metabolism.

[36]  G. Hotamisligil,et al.  Inflammation and endoplasmic reticulum stress in obesity and diabetes , 2008, International Journal of Obesity.

[37]  Philip A Kern,et al.  Adipocytokines and the metabolic complications of obesity. , 2008, The Journal of clinical endocrinology and metabolism.

[38]  B. Levin,et al.  Effects of leptin on rat ventromedial hypothalamic neurons. , 2008, Endocrinology.

[39]  V. Dixit.  Adipose‐immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span , 2008, Journal of leukocyte biology.

[40]  E. Bernal-Mizrachi,et al.  β-cell failure as a complication of diabetes , 2008, Reviews in Endocrine and Metabolic Disorders.

[41]  Tamas L. Horvath,et al.  UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals , 2008, Nature.

[42]  H. Münzberg.  Differential leptin access into the brain — A hierarchical organization of hypothalamic leptin target sites? , 2008, Physiology & Behavior.

[43]  S. Markovic‐Plese,et al.  Statins’ immunomodulatory potential against Th17 cell-mediated autoimmune response , 2008, Immunologic research.

[44]  A. Tedgui,et al.  Regulatory T‐cell immunity and its relevance to atherosclerosis , 2008, Journal of internal medicine.

[45]  D. Eizirik,et al.  The role for endoplasmic reticulum stress in diabetes mellitus. , 2008, Endocrine reviews.

[46]  T. Horvath,et al.  Neuronal control of energy homeostasis , 2008, FEBS letters.

[47]  K. Clément,et al.  Defective Leptin/Leptin Receptor Signaling Improves Regulatory T Cell Immune Response and Protects Mice From Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[48]  B. Strober,et al.  Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review , 2007, The British journal of dermatology.

[49]  E. Shevach,et al.  Foxp3+ regulatory T cells: selfishness under scrutiny. , 2007, Immunity.

[50]  Allan Vaag,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[51]  U. Smith,et al.  Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? , 2007, Diabetologia.

[52]  V. De Rosa,et al.  A key role of leptin in the control of regulatory T cell proliferation. , 2007, Immunity.

[53]  Jun Ren,et al.  Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. , 2007, Current diabetes reviews.

[54]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[55]  T. Horvath,et al.  Thoughts for Food: Brain Mechanisms and Peripheral Energy Balance , 2006, Neuron.

[56]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[57]  Thorsten Buch,et al.  Agouti-related peptide–expressing neurons are mandatory for feeding , 2005, Nature Neuroscience.

[58]  T. Horvath.  The hardship of obesity: a soft-wired hypothalamus , 2005, Nature Neuroscience.

[59]  H. Münzberg,et al.  Molecular and anatomical determinants of central leptin resistance , 2005, Nature Neuroscience.

[60]  V. De Rosa,et al.  Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[61]  S. Sakaguchi.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[62]  R. Robertson.  Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes* , 2004, Journal of Biological Chemistry.

[63]  J. Flier,et al.  Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3 , 2004, Nature Medicine.

[64]  A. Yoshimura,et al.  Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity , 2004, Nature Medicine.

[65]  G. Matarese,et al.  The weight of leptin in immunity , 2004, Nature Reviews Immunology.

[66]  A. La Cava,et al.  The intricate interface between immune system and metabolism. , 2004, Trends in immunology.

[67]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[68]  V. Sánchez-Margalet,et al.  Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV‐infected patients , 2003, Clinical and experimental immunology.

[69]  J. Pfeilschifter,et al.  Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. , 2003, Diabetes.

[70]  W. Banks,et al.  Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. , 2003, American journal of physiology. Endocrinology and metabolism.

[71]  V. Sánchez-Margalet,et al.  Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action , 2003, Clinical and experimental immunology.

[72]  P. Garcia-Lorda,et al.  Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. , 2003, Obesity research.

[73]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[74]  R. Sun,et al.  Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. , 2003, Biochemical and biophysical research communications.

[75]  R. Sun,et al.  Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. , 2002, Biochemical and biophysical research communications.

[76]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[77]  Graham M Lord,et al.  Leptin inhibits the anti‐CD3‐driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines , 2002, Journal of leukocyte biology.

[78]  J. Waring,et al.  Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. , 2002, Diabetes.

[79]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[80]  Graham M Lord,et al.  Balancing susceptibility to infection and autoimmunity: a role for leptin? , 2002, Trends in immunology.

[81]  T. Mimori,et al.  Leptin inhibits stress‐induced apoptosis of T lymphocytes , 2002, Clinical and experimental immunology.

[82]  H. Ochs,et al.  IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena , 2001, Current opinion in pediatrics.

[83]  Sayuri Yamazaki,et al.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance , 2001, Immunological reviews.

[84]  Graham M Lord,et al.  Requirement for Leptin in the Induction and Progression of Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.

[85]  T. Yamakawa,et al.  T lymphopaenia in relation to body mass index and TNF‐α in human obesity: adequate weight reduction can be corrective , 2001, Clinical endocrinology.

[86]  F. Caldefie‐Chézet,et al.  Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? , 2001, Journal of leukocyte biology.

[87]  Young-Bum Kim,et al.  Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.

[88]  Alexander S. Banks,et al.  Activation of Downstream Signals by the Long Form of the Leptin Receptor* , 2000, The Journal of Biological Chemistry.

[89]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[90]  V. Sánchez-Margalet,et al.  Human leptin enhances activation and proliferation of human circulating T lymphocytes. , 2000, Cellular immunology.

[91]  Graham M Lord,et al.  Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. , 1999, The Journal of clinical investigation.

[92]  V. Sánchez-Margalet,et al.  Human leptin stimulates proliferation and activation of human circulating monocytes. , 1999, Cellular immunology.

[93]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[94]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[95]  K. Clément,et al.  A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.

[96]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[97]  Stephen R. Bloom,et al.  Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression , 1998, Nature.

[98]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[99]  K. Clément,et al.  A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction , 1998, Nature.

[100]  S. O’Rahilly,et al.  Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene , 1997, Nature Genetics.

[101]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[102]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[103]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[104]  B. Spiegelman,et al.  Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.

[105]  B. Spiegelman,et al.  Through thick and thin: Wasting, obesity, and TNFα , 1993, Cell.

[106]  J. Clot,et al.  Early effects of thyroidectomy and triiodothyronine administration on rat-liver mitochondria , 1979, Molecular and Cellular Endocrinology.

[107]  Shimon Sakaguchi,et al.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity , 2010, Nature Immunology.

[108]  S. Sebert,et al.  Nutritional programming of the metabolic syndrome , 2009, Nature Reviews Endocrinology.

[109]  A. Pinchera,et al.  Melanocortin-4 receptor mutations in obesity. , 2009, Advances in clinical chemistry.

[110]  David Metcalfe,et al.  Obesity and diabetes: lipids, 'nowhere to run to'. , 2009, Clinical science.

[111]  K. Cianflone,et al.  Adipokines and the immune system: an adipocentric view. , 2008, Advances in experimental medicine and biology.

[112]  Ruojing Yang,et al.  c-Jun N-terminal kinase pathways in diabetes. , 2008, The international journal of biochemistry & cell biology.

[113]  T. Horvath,et al.  Developmental programming of the hypothalamus: a matter of fat , 2006, Nature Medicine.

[114]  A. Freitas,et al.  IPEX and FOXP3: clinical and research perspectives. , 2005, Journal of autoimmunity.

[115]  Supporting Online Material , 2002 .

[116]  W. A. Banks,et al.  Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. , 2001, Current pharmaceutical design.

[117]  A. Zinn,et al.  Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. , 2000, Human molecular genetics.